GlassScriptPhysician profile
Johnny J Stephens
NPI 1093703738
$1,121.83
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $257 · 2021: $370 · 2022: $41.20.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $202.64 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $184.05 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $140.75 | 2019-2021 | |
| Exelixis INC. | $123.60 | 2021-2022 | |
| Genentech USA, INC. | $81.72 | 2019-2020 | |
| Astellas Pharma US INC | $55.93 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $47.93 | 2019-2020 | |
| Seagen INC. | $37.78 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $32.31 | 2021 | |
| Array Biopharma INC | $28.72 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.64 | 2021 | |
| Glaxosmithkline, LLC. | $21.46 | 2021 | |
| Genzyme Corporation | $20.59 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $19.66 | 2021 | |
| Daiichi Sankyo INC. | $16.62 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.00 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.65 | 2021 | |
| Janssen Biotech, INC. | $14.33 | 2021 | |
| Biotronik INC. | $13.67 | 2021 | |
| Pfizer INC. | $12.63 | 2020 | |
| Kyowa Kirin, INC. | $11.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.